NCT05946369
- Conditions
- BCG, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Ain Shams university Cairo, Egypt
Clinical trial condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Explore clinical trials studying Non-Muscle Invasive Bladder Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.
12 public trials
8 recruiting studies
Non-Muscle Invasive Bladder Urothelial Carcinoma trial results
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT04164082
- Conditions
- Bladder Flat Urothelial Carcinoma In Situ, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States